Literature DB >> 19623203

No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals.

G K Pot1, I A Brouwer, A Enneman, G T Rijkers, E Kampman, A Geelen.   

Abstract

BACKGROUND: A high intake of n-3 polyunsaturated fatty acids (PUFAs), mainly present in fish, may be associated with decreased inflammation. Previous intervention studies on fish PUFA and inflammatory markers in healthy individuals did not analyze a broad spectrum of inflammatory cytokines, chemokines and cell adhesion molecules, or their interrelationships. Therefore, we determined the effects of fish oil supplementation on 19 serum inflammatory markers and their interrelationships in healthy, middle-aged individuals.
METHODS: Individuals (n=77) aged 50-70 years completed a randomized, double-blind placebo-controlled intervention study. Participants received 3.5 g/day fish oil (1.5 g/day total n-3 PUFA) (n=39) or placebo (high oleic sunflower oil) (n=38) for 12 weeks. Serum concentrations of 19 inflammatory markers were determined using a multiplex immunoassay before and after intervention. Changes in concentrations were analyzed using analysis of covariance and differences in patterns in inflammatory markers between the fish oil and placebo group were analyzed by principal component analysis.
RESULTS: Fish oil supplementation did not significantly affect serum concentrations of cytokines, chemokines or cell adhesion molecules as compared with placebo. However, there was a trend for all inflammatory markers to increase after fish oil supplementation. PCA did not result in markedly distinctive patterns of inflammatory markers for the fish oil and placebo group.
CONCLUSION: In conclusion, this 12-week randomized, double-blind placebo-controlled intervention trial did not show that 1.5 g/day n-3 PUFA significantly affected the serum inflammatory response in healthy individuals, nor did patterns of inflammatory markers. Thus, a healthy middle-aged population may not benefit from fish oil as an anti-inflammatory agent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19623203     DOI: 10.1038/ejcn.2009.63

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  21 in total

Review 1.  The evidence for α-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid.

Authors:  Jennifer A Fleming; Penny M Kris-Etherton
Journal:  Adv Nutr       Date:  2014-11-14       Impact factor: 8.701

2.  Supplementation with eicosapentaenoic acid and docosahexaenoic acid reduces high levels of circulating proinflammatory cytokines in aging adults: A randomized, controlled study.

Authors:  Alai Tan; Brent Sullenbarger; Ruchika Prakash; Jodi C McDaniel
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-04-03       Impact factor: 4.006

3.  Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis.

Authors:  C Custodero; R T Mankowski; S A Lee; Z Chen; S Wu; T M Manini; J Hincapie Echeverri; C Sabbà; D P Beavers; J A Cauley; M A Espeland; R A Fielding; S B Kritchevsky; C K Liu; M M McDermott; M E Miller; R P Tracy; A B Newman; W T Ambrosius; M Pahor; S D Anton
Journal:  Ageing Res Rev       Date:  2018-05-25       Impact factor: 10.895

4.  Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome.

Authors:  Antonella Dewell; Farshad Fani Marvasti; William S Harris; Philip Tsao; Christopher D Gardner
Journal:  J Nutr       Date:  2011-10-26       Impact factor: 4.798

Review 5.  Role of fish oil in human health and possible mechanism to reduce the inflammation.

Authors:  Mohammed S Ellulu; Huzwah Khaza'ai; Yehia Abed; Asmah Rahmat; Patimah Ismail; Yazan Ranneh
Journal:  Inflammopharmacology       Date:  2015-02-14       Impact factor: 4.473

Review 6.  N-3 polyunsaturated fatty acids: relationship to inflammation in healthy adults and adults exhibiting features of metabolic syndrome.

Authors:  Lindsay E Robinson; Vera C Mazurak
Journal:  Lipids       Date:  2013-03-01       Impact factor: 1.880

7.  Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults.

Authors:  Michael R Flock; Ann C Skulas-Ray; William S Harris; Trent L Gaugler; Jennifer A Fleming; Penny M Kris-Etherton
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-07-17       Impact factor: 4.006

Review 8.  Long-term effects of increasing omega-3, omega-6 and total polyunsaturated fats on inflammatory bowel disease and markers of inflammation: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Sarah M Ajabnoor; Gabrielle Thorpe; Asmaa Abdelhamid; Lee Hooper
Journal:  Eur J Nutr       Date:  2020-10-21       Impact factor: 5.614

9.  Fish oil supplementation does not lower C-reactive protein or interleukin-6 levels in healthy adults.

Authors:  M F Muldoon; B Laderian; D C H Kuan; S M Sereika; A L Marsland; S B Manuck
Journal:  J Intern Med       Date:  2015-10-26       Impact factor: 8.989

10.  An Oily Fish Diet Improves Subclinical Inflammation in People at High Cardiovascular Risk: A Randomized Controlled Study.

Authors:  Giuseppina Costabile; Giuseppe Della Pepa; Claudia Vetrani; Paola Vitaglione; Ettore Griffo; Rosalba Giacco; Marilena Vitale; Dominic Salamone; Angela Albarosa Rivellese; Giovanni Annuzzi; Lutgarda Bozzetto
Journal:  Molecules       Date:  2021-06-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.